Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
Authors: Anne M. Hause, James Baggs, Paige Marquez, Winston E. Abara, Jane Gwira Baumblatt, Deborah Thompson, John R. Su, Tanya R. Myers, Julianne Gee, Tom T. Shimabukuro, David K. Shay